Enteric Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

Bacterial Enteric Diseases Segment is the fastest growing segment, North America is the largest market globally

The Global Enteric Disease Testing Market, valued at USD 4.12 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 5.48 Billion by 2030. Enteric disease testing encompasses diagnostic procedures designed to identify infections affecting the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. The global market for these tests is primarily driven by the escalating prevalence of enteric infections worldwide and continuous advancements in diagnostic methodologies.

Key Market Drivers

The increasing global burden of enteric infections significantly fuels the demand for diagnostic testing solutions. The widespread prevalence of these infections, often exacerbated by inadequate sanitation and contaminated food or water, necessitates robust surveillance and rapid identification to manage outbreaks and prevent further spread. For instance, according to the CDC's Foodborne Diseases Active Surveillance Network (FoodNet) 2023 Preliminary Data, the incidence of infections from pathogens such as Campylobacter, Cyclospora, Shiga toxin-producing E. coli (STEC), Vibrio, and Yersinia increased in 2023 compared with the 2016-2018 baseline, underscoring a persistent and growing threat. Concurrently, technological innovations in diagnostic testing are transforming the market by offering more accurate, faster, and accessible detection methods, including molecular diagnostics, immunoassays, and point-of-care platforms.

Key Market Challenges

The elevated costs associated with developing and implementing advanced diagnostic technologies present a significant impediment to the growth of the Global Enteric Disease Testing Market. These high expenditures directly limit the adoption of sophisticated testing platforms, particularly within healthcare systems operating in resource-constrained environments. Such financial barriers restrict access to accurate and rapid diagnostics, leading to delayed diagnoses and treatment for enteric infections. This directly reduces the market penetration of advanced solutions, as facilities are often compelled to prioritize less expensive, albeit potentially less effective, testing methods.

Key Market Trends

Digital health integration within diagnostic workflows is a pivotal trend, streamlining how patient data is collected, shared, and managed. This development connects diagnostic platforms with electronic health records and telehealth systems, enhancing efficiency and accessibility. According to the CDC, in April 2024, over 36,000 healthcare facilities could send electronic case reports, an increase from over 25,000 in early 2023, facilitating quicker public health responses to infectious disease threats. This interconnectivity supports comprehensive patient management and rapid epidemiological surveillance.

Key Market Players Profiled:

• Abbott Laboratories Ltd.
• Becton Dickinson & Co.
• Biomerica Inc.
• BioMérieux SA
• Bio-Rad Laboratories, Inc.
• Cepheid
• Coris BioConcept
• DiaSorin S.p.A.
• Meridian Bioscience Inc.
• Quest Diagnostics Incorporated

Report Scope:

In this report, the Global Enteric Disease Testing Market has been segmented into the following categories:

By Disease Type:

• Bacterial Enteric Diseases
• Viral Enteric Diseases
• Parasitic Enteric Diseases
• Rotavirus
• Norovirus

By End-User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

By Region:

• North America
• Europe
• Asia-Pacific
• Soth America
• MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Enteric Disease Testing Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.